Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 827-845
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.827
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.827
Figure 2 Effect of intravenous continuous atrial natriuretic peptide infusion on sodium excretion (μmol/min).
Analyses were performed on overall data and separately for studies applying low dose infusion (≤ 30 ng/kg/min) and high dose infusion (> 30 ng/kg/min). ANP: Atrial natriuretic peptide; CI: Confidence interval.
- Citation: Gantzel RH, Kjær MB, Jepsen P, Aagaard NK, Watson H, Gluud LL, Grønbæk H. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World J Hepatol 2022; 14(4): 827-845
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/827.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.827